# Stricture Definition and Treatment (STRIDENT) Drug Therapy Study

> **NCT03220841** · PHASE4 · UNKNOWN · sponsor: **St Vincent's Hospital Melbourne** · enrollment: 78 (actual)

## Conditions studied

- Crohn Disease
- Inflammatory Bowel Diseases
- Stricture; Bowel

## Interventions

- **DRUG:** Adalimumab Injection
- **DRUG:** Thiopurine
- **PROCEDURE:** Endoscopic balloon dilatation

## Key facts

- **NCT ID:** NCT03220841
- **Lead sponsor:** St Vincent's Hospital Melbourne
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-10-09
- **Primary completion:** 2020-09-18
- **Final completion:** 2021-09
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2020-10-23

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03220841

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03220841, "Stricture Definition and Treatment (STRIDENT) Drug Therapy Study". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03220841. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*